Pear Bio is a pioneering brand in the field of personalized cancer treatment and precision trials. They recognize that cancer is a constantly evolving disease that develops drug resistance and spreads within the body. To combat this, Pear Bio utilizes patient tumor samples to track cancer progression and understand how cancer migration and drug resistance develop over time.

With the help of their advanced computer vision tools, they analyze time-lapsed, live-cell 3D images to predict how individual patients would respond to different drugs or combinations. Additionally, Pear Bio's models are also applied to immuno-oncology, combining patient tumor samples with matched immune cells to monitor immune-cancer dynamics and measure the efficacy of immunotherapy. Their technology has three main applications: personalized cancer medicine, clinical trials, and pharma R&D.

By helping doctors eliminate ineffective cancer regimens, matching suitable patients with experimental drugs, and assisting pharma companies in discovering biomarkers and patient populations for new drug development, Pear Bio is revolutionizing cancer treatment and research